威尔明顿消息:美国杜邦药物公司正计划用一种长效纳洛酮同类药进行临床试验.大白鼠试验证明,纳洛酮可预防大白鼠进食过多。肥胖.公司的代言人说,他们认为另一种药Naltrexone比纳洛酮治疗肥胖症更有希望. 上述两种药物均属麻醉药措抗剂.给予纳洛国后,可以阻断吗啡成病者脑内结合鸦片的受体.Naltrexone可以口服.人脑所产生的某些物质似乎可起到与吗啡相同的作用,而且这些物质与某些重要的脑活动(如控制疼痛)和情绪表达等有关.目前,至少已有证据表明,动物脑中鸦片u内啡吠)可能促进肥胖.费城坦普尔大学肥胖研究基金会David Margules Wilmington: DuPont Pharmaceuticals is planning to conduct a clinical trial of a long-acting naloxone-based drug, which shows that naloxone can prevent rats from eating too much. Obesity.The spokesman for the company said they think the other drug, naltrexone, is more promising than naloxone in the treatment of obesity, both of which are anesthetic drug antagonists that, when administered to naloxone, block the onset of morphine morbidity Naltrexone can be taken orally, and some of the substances produced by the human brain seem to play the same role as morphine, and these substances are associated with certain important brain activities such as controlling pain and emotional expression .At present, at least, there is evidence that opium in the animal brain is likely to promote obesity. David Margules, Research Foundation for Obesity, Temple University, Philadelphia